Pell Wardrop, MD
Sleep Medicine · Lexington, KYNPI 1881689693
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,853 of the $2,081 with a category attached, or 89.0%. 11 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 41.7% of the total.
Across 86 payments — averaging $24.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$868
- Harmony Biosciences LLC$505
- Axsome Therapeutics, Inc.$196
- Idorsia Pharmaceuticals US Inc$155
- Azurity Pharmaceuticals, Inc.$108
- Arbor Pharmaceuticals, Inc.$99
- plus $150 from 5 others
What the payments were for
- Food & beverage$1,85389%
- Education$22911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 32 | $868 |
| Harmony Biosciences LLC | 21 | $505 |
| Axsome Therapeutics, Inc. | 10 | $196 |
| Idorsia Pharmaceuticals US Inc | 3 | $155 |
| Azurity Pharmaceuticals, Inc. | 6 | $108 |
| Arbor Pharmaceuticals, Inc. | 7 | $99 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $60 |
| 3b Medical, Inc. | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Resmed Corp | 1 | $19 |
| Fisher & Paykel Healthcare Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,081 in reported general payments places this provider in the 65th percentile of 28 sleep medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 20 | $940 |
| Modafinil | 18 | $610 |
| Gabapentin | 28 | $270 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Lexington
- Robert MurrayLexington$994
- David HiestandLexington$400
- Sara PashaLexington$181
- Kevin TriceLouisville$220K
- Michael ZachekBowling Green$34K
- Klark TurpenGlasgow$7K
- William LacyLouisville$6K
- Abinash JoshiOwensboro$6K
- Kate YoungElizabethtown$4K
- Robert KarmanLouisville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.